GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Kimia Farma Tbk (ISX:KAEF) » Definitions » Revenue

PT Kimia Farma Tbk (ISX:KAEF) Revenue : Rp10,114,020 Mil (TTM As of Sep. 2024)


View and export this data going back to 2001. Start your Free Trial

What is PT Kimia Farma Tbk Revenue?

PT Kimia Farma Tbk's revenue for the three months ended in Sep. 2024 was Rp2,650,569 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2024 was Rp10,114,020 Mil. PT Kimia Farma Tbk's Revenue per Share for the three months ended in Sep. 2024 was Rp475.44. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was Rp1,817.47.

Warning Sign:

PT Kimia Farma Tbk revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of PT Kimia Farma Tbk was 3.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was -1.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was 2.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 10.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, PT Kimia Farma Tbk's highest 3-Year average Revenue per Share Growth Rate was 20.30% per year. The lowest was -1.90% per year. And the median was 10.20% per year.


PT Kimia Farma Tbk Revenue Historical Data

The historical data trend for PT Kimia Farma Tbk's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kimia Farma Tbk Revenue Chart

PT Kimia Farma Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9,400,535.48 10,006,173.02 12,857,626.59 9,232,675.97 9,965,033.05

PT Kimia Farma Tbk Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,768,838.37 2,249,756.30 2,535,778.85 2,677,916.63 2,650,568.51

Competitive Comparison of PT Kimia Farma Tbk's Revenue

For the Medical Distribution subindustry, PT Kimia Farma Tbk's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Kimia Farma Tbk's Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Kimia Farma Tbk's Revenue distribution charts can be found below:

* The bar in red indicates where PT Kimia Farma Tbk's Revenue falls into.


;
;

PT Kimia Farma Tbk Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp10,114,020 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Kimia Farma Tbk  (ISX:KAEF) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


PT Kimia Farma Tbk Revenue Related Terms

Thank you for viewing the detailed overview of PT Kimia Farma Tbk's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Kimia Farma Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.

PT Kimia Farma Tbk Headlines

No Headlines